Literature DB >> 20015251

Expectation of life and unexpected death in open spina bifida: a 40-year complete, non-selective, longitudinal cohort study.

Pippa Oakeshott1, Gillian M Hunt, Alison Poulton, Fiona Reid.   

Abstract

AIM: The aim of our study was to investigate survival and causes of death in a complete cohort of open spina bifida at the mean age of 40 years.
METHOD: We conducted a community-based, prospective study of 117 consecutive infants (50 males, 67 females) with open spina bifida whose backs were closed non-selectively within 48 hours of birth between 1963 and 1971 at Addenbrooke's Hospital, Cambridge, UK. Of those who survived to age 1 year, 89% (82 out of 92) had a cerebrospinal fluid shunt. In 2007, all survivors were surveyed by postal questionnaire backed up by telephone interview. Details of deaths were obtained from the Office for National Statistics, medical records, and autopsy reports, and Kaplan-Meier survival curves were constructed.
RESULTS: One in three of the cohort (40/117) died before the age of 5 years. A further 26% (31/117) died during the next 35 years, over 10 times the national average. Half the deaths (16/31) after the age of 5 were sudden and unexpected. All occurred in the community and were followed by a coroner's autopsy. The most frequent causes of these unexpected deaths were epilepsy, pulmonary embolus, acute hydrocephalus, and acute renal sepsis. The prognosis for survival was strikingly poor in those with the most extensive neurological deficit. Only 17% (7/42) of those born with a high sensory level (above T11) survived to the mean age of 40 years, compared with 61% (23/38) of those with a low sensory level (below L3; p=0.001).
INTERPRETATION: Doctors and care planners need to be aware that, contrary to previous suggestions, there is continuing high mortality throughout adult life in individuals with open spina bifida, and many deaths are unexpected.

Entities:  

Mesh:

Year:  2009        PMID: 20015251     DOI: 10.1111/j.1469-8749.2009.03543.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  35 in total

1.  Short-term prognostic factors in myelomeningocele patients.

Authors:  Andre Broggin Dutra Rodrigues; Vera Lucia Jornada Krebs; Hamilton Matushita; Werther Brunow de Carvalho
Journal:  Childs Nerv Syst       Date:  2016-01-11       Impact factor: 1.475

Review 2.  Spina bifida in pregnancy: A review of the evidence for preconception, antenatal, intrapartum and postpartum care.

Authors:  Kenga Sivarajah; Sophie Relph; Radha Sabaratnam; Spyros Bakalis
Journal:  Obstet Med       Date:  2018-05-17

3.  Prospective and episodic memory in relation to hippocampal volume in adults with spina bifida myelomeningocele.

Authors:  Amery Treble-Barna; Jenifer Juranek; Karla K Stuebing; Paul T Cirino; Maureen Dennis; Jack M Fletcher
Journal:  Neuropsychology       Date:  2014-07-28       Impact factor: 3.295

4.  Mutations in folate transporter genes and risk for human myelomeningocele.

Authors:  Tina O Findley; Joy C Tenpenny; Michelle R O'Byrne; Alanna C Morrison; James E Hixson; Hope Northrup; Kit Sing Au
Journal:  Am J Med Genet A       Date:  2017-09-26       Impact factor: 2.802

Review 5.  Spina bifida.

Authors:  Alvaro A Saavedra; Dawn Maclellan; Gary J Gray
Journal:  Can Urol Assoc J       Date:  2018-04       Impact factor: 1.862

6.  Maternal-fetal surgery for myelomeningocele: some thoughts on ethical, legal, and psychological issues in a Western European situation.

Authors:  Frank Van Calenbergh; Luc Joyeux; Jan Deprest
Journal:  Childs Nerv Syst       Date:  2017-05-23       Impact factor: 1.475

Review 7.  New directions in fetal surgery for myelomeningocele.

Authors:  Sandra K Kabagambe; Y Julia Chen; Melissa A Vanover; Payam Saadai; Diana L Farmer
Journal:  Childs Nerv Syst       Date:  2017-05-11       Impact factor: 1.475

8.  First 60 fetal in-utero myelomeningocele repairs at Saint Louis Fetal Care Institute in the post-MOMS trial era: hydrocephalus treatment outcomes (endoscopic third ventriculostomy versus ventriculo-peritoneal shunt).

Authors:  Samer K Elbabaa; Anne M Gildehaus; Matthew J Pierson; J Andrew Albers; Emanuel J Vlastos
Journal:  Childs Nerv Syst       Date:  2017-05-03       Impact factor: 1.475

9.  The fate of transitional urology patients referred to a tertiary transitional care center.

Authors:  Robert Chan; Jason Scovell; Zachary Jeng; Saneal Rajanahally; Timothy Boone; Rose Khavari
Journal:  Urology       Date:  2014-12       Impact factor: 2.649

10.  Strengthening the argument for rapid brain MR imaging: estimation of reduction in lifetime attributable risk of developing fatal cancer in children with shunted hydrocephalus by instituting a rapid brain MR imaging protocol in lieu of Head CT.

Authors:  K Koral; T Blackburn; A A Bailey; K M Koral; J Anderson
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-03       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.